IOL Chemicals zooms on securing approval for Ibuprofen from CDE in China

29 Apr 2025 Evaluate

IOL Chemicals and Pharmaceuticals is currently trading at Rs. 68.29, up by 2.87 points or 4.39% from its previous closing of Rs. 65.42 on the BSE.

The scrip opened at Rs. 67.90 and has touched a high and low of Rs. 69.89 and Rs. 67.60 respectively. So far 86175 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 107.41 on 16-Sep-2024 and a 52 week low of Rs. 57.51 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 70.90 and Rs. 63.46 respectively. The current market cap of the company is Rs. 1998.34 crore.

The promoters holding in the company stood at 52.62%, while Institutions and Non-Institutions held 1.54% and 45.84% respectively.

IOL Chemicals and Pharmaceuticals has received approval for ‘Ibuprofen’ product from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), China. This approval authorizes the company to export Ibuprofen to the Chinese markets. Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID) effective in relieving pain, reducing inflammation, and lowering fever.

IOL Chemicals and Pharmaceuticals is India's one of the leading generic pharmaceutical companies, and is significant player in the Organic chemicals space.

IOL Chem & Pharma Share Price

83.90 1.79 (2.18%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×